David B. Weiner

CIK: 0001669080

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (66.7%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INO

INOVIO PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

INO
INOVIO PHARMACEUTICALS, INC.
May 20, 2026
Award(A)
Common Stock Options
Direct
41.8K shares-
INO
INOVIO PHARMACEUTICALS, INC.
May 20, 2026
Award(A)
Restricted Stock Unit
Direct
34.2K shares-
INO
INOVIO PHARMACEUTICALS, INC.
Feb 26, 2026
Exercise(M)
Direct
972 shares-
INO
INOVIO PHARMACEUTICALS, INC.
May 21, 2025
Exercise(M)
Direct
2.2K shares-
INO
INOVIO PHARMACEUTICALS, INC.
Feb 26, 2025
Exercise(M)
Direct
972 shares-
INO
INOVIO PHARMACEUTICALS, INC.
Feb 26, 2025
Exercise(M)
Direct
972 shares-

		Type	Shares	Price		Ownership
May 20, 2026	INO INOVIO PHARMACEUTICALS, INC.	Award(A) Common Stock Options	41,800	-	-	Direct
May 20, 2026	INO INOVIO PHARMACEUTICALS, INC.	Award(A) Restricted Stock Unit	34,200	-	-	Direct
Feb 26, 2026	INO INOVIO PHARMACEUTICALS, INC.	Exercise(M)	972	-	$0	Direct
May 21, 2025	INO INOVIO PHARMACEUTICALS, INC.	Exercise(M)	2,167	-	-	Direct
Feb 26, 2025	INO INOVIO PHARMACEUTICALS, INC.	Exercise(M)	972	-	-	Direct
Feb 26, 2025	INO INOVIO PHARMACEUTICALS, INC.	Exercise(M)	972	-	-	Direct

1-6 of 6 transactions

About Weiner David B.

Weiner David B. (SEC CIK 0001669080) files insider reports with the SEC as Director of INOVIO PHARMACEUTICALS, INC. (INO).

Signal8 holds 4 ownership filings by Weiner David B., all Form 4s, filed between Feb 28, 2025 and May 21, 2026. Those filings report 6 transactions, from Feb 26, 2025 to May 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Weiner David B.'s filings is in PLYMOUTH MEETING, PA.

Recent filings by Weiner David B.

May 20, 2026: Grants or awards of INO derivative securities (2 lines, Form 4, code A).
Feb 26, 2026: Option exercise of INO shares (Form 4, code M).
May 21, 2025: Option exercise of INO shares (Form 4, code M).
Feb 26, 2025: Option exercises of INO shares (2 lines, Form 4, code M).

Other insiders filing for INOVIO PHARMACEUTICALS, INC. (INO)

YARNO WENDY L, Director
Shepard Jay, Director
Miller Ann Calby, Director
Zoth Lota S., Director
DANSEY ROGER D, Director
BENITO SIMON X, Director

How to read Form 4 transaction codes